author-photo

Kinjal Mody

4

Papers

34

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

798 Safety, tolerability, and immunogenicity of mRNA-4157 in combination with pembrolizumab in subjects with unresectable solid tumors (KEYNOTE-603): an update

2020 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors.

2019 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (24)
A phase 1, open-label, multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in subjects with resected solid tumors and in combination with pembrolizumab in subjects with unresectable solid tumors (Keynote-603).

2019 Journal of Global Oncology
Show All
- Source
- Cite
- Save
Citations (5)